These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 29332140)

  • 1. Identification of Cross Reactive Antigens of C. botulinum Types A, B, E & F by Immunoproteomic Approach.
    Sharma A; Ponmariappan S; Sarita R; Alam SI; Kamboj DV; Shukla S
    Curr Microbiol; 2018 May; 75(5):531-540. PubMed ID: 29332140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoproteomics Approach for Screening of Vaccine Candidates against Intestinal Botulism.
    Sharma A; Rani S; Alam SI; Ponmariappan S
    Protein Pept Lett; 2017; 24(8):771-780. PubMed ID: 28393685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
    Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
    Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoproteomic analysis of Clostridium botulinum type B secretome for identification of immunogenic proteins against botulism.
    Sharma A; Ponmariappan S; Rani S; Alam SI; Shukla S
    Biotechnol Lett; 2021 May; 43(5):1019-1036. PubMed ID: 33629143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High level expression and immunochemical characterization of botulinum neurotoxin type F light chain.
    Chauhan R; Chauhan V; Rao MK; Chaudhary D; Bhagyawant S; Dhaked RK
    Protein Expr Purif; 2018 Jun; 146():51-60. PubMed ID: 29407166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective potential of recombinant non-purified botulinum neurotoxin serotypes C and D.
    Moreira C; da Cunha CE; Moreira GM; Mendonça M; Salvarani FM; Moreira ÂN; Conceição FR
    Anaerobe; 2016 Aug; 40():58-62. PubMed ID: 27236078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of immunodetection system for botulinum neurotoxin serotype E.
    Sarita R; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
    Indian J Med Res; 2018 Jun; 147(6):603-610. PubMed ID: 30168493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of recombinant botulism antigens: a review of expression systems.
    Moreira GM; Cunha CE; Salvarani FM; Gonçalves LA; Pires PS; Conceição FR; Lobato FC
    Anaerobe; 2014 Aug; 28():130-6. PubMed ID: 24930432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of toxin-producing Clostridium botulinum with the macroalga Cladophora in the Great Lakes.
    Chun CL; Ochsner U; Byappanahalli MN; Whitman RL; Tepp WH; Lin G; Johnson EA; Peller J; Sadowsky MJ
    Environ Sci Technol; 2013 Mar; 47(6):2587-94. PubMed ID: 23421373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulism and vaccines for its prevention.
    Smith LA
    Vaccine; 2009 Nov; 27 Suppl 4():D33-9. PubMed ID: 19837283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversity of the Genomes and Neurotoxins of Strains of
    Brunt J; van Vliet AHM; Carter AT; Stringer SC; Amar C; Grant KA; Godbole G; Peck MW
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32932818
    [No Abstract]   [Full Text] [Related]  

  • 12. Potent tetravalent replicon vaccines against botulinum neurotoxins using DNA-based Semliki Forest virus replicon vectors.
    Yu YZ; Guo JP; An HJ; Zhang SM; Wang S; Yu WY; Sun ZW
    Vaccine; 2013 May; 31(20):2427-32. PubMed ID: 23583890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory diagnostics of botulism.
    Lindström M; Korkeala H
    Clin Microbiol Rev; 2006 Apr; 19(2):298-314. PubMed ID: 16614251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of vaccines for prevention of botulism.
    Byrne MP; Smith LA
    Biochimie; 2000; 82(9-10):955-66. PubMed ID: 11086225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinction between Clostridium botulinum type A strains associated with food-borne botulism and those with infant botulism in Japan in intraintestinal toxin production in infant mice and some other properties.
    Tabita K; Sakaguchi S; Kozaki S; Sakaguchi G
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):251-6. PubMed ID: 1905658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New targets in the search for preventive and therapeutic agents for botulism.
    Anniballi F; Lonati D; Fiore A; Auricchio B; De Medici D; Locatelli CA
    Expert Rev Anti Infect Ther; 2014 Sep; 12(9):1075-86. PubMed ID: 25089560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism.
    Webb RP; Smith TJ; Smith LA; Wright PM; Guernieri RL; Brown JL; Skerry JC
    Toxins (Basel); 2017 Sep; 9(9):. PubMed ID: 28869522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with recombinant whole heavy chain fragments of Clostridium botulinum Type C and D neurotoxins.
    Arimitsu H; Lee JC; Sakaguchi Y; Hayakawa Y; Hayashi M; Nakaura M; Takai H; Lin SN; Mukamoto M; Murphy T; Oguma K
    Clin Diagn Lab Immunol; 2004 May; 11(3):496-502. PubMed ID: 15138174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Clostridium botulinum types C and D toxoid vaccination in Danish cows.
    Krüger M; Skau M; Shehata AA; Schrödl W
    Anaerobe; 2013 Oct; 23():97-101. PubMed ID: 23831724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory Networks Controlling Neurotoxin Synthesis in
    Popoff MR; Brüggemann H
    Toxins (Basel); 2022 May; 14(6):. PubMed ID: 35737025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.